• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.

作者信息

van Noesel Jan, van der Ven Ward H, van Os Theo A M, Kunst Peter W A, Weegenaar Jitske, Reinten Roy J A, Kancha Rama K, Duyster Justus, van Noesel Carel J M

机构信息

Academic Medical Center, Amsterdam, The Netherlands.

出版信息

J Clin Oncol. 2013 Apr 1;31(10):e161-4. doi: 10.1200/JCO.2012.42.1586. Epub 2013 Jan 28.

DOI:10.1200/JCO.2012.42.1586
PMID:23358982
Abstract
摘要

相似文献

1
Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.表皮生长因子受体中的种系R776H激活突变与肺鳞状分化癌相关。
J Clin Oncol. 2013 Apr 1;31(10):e161-4. doi: 10.1200/JCO.2012.42.1586. Epub 2013 Jan 28.
2
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.一名表皮生长因子受体（EGFR）突变的非小细胞肺癌（NSCLC）患者在接受EGFR酪氨酸激酶抑制剂治疗后转变为鳞状细胞癌表型。
J Clin Pathol. 2015 Apr;68(4):320-1. doi: 10.1136/jclinpath-2015-202866. Epub 2015 Feb 6.
3
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.中国非小细胞肺癌患者表皮生长因子受体酪氨酸激酶结构域的吉非替尼敏感突变
Clin Cancer Res. 2005 Jun 15;11(12):4289-94. doi: 10.1158/1078-0432.CCR-04-2506.
4
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastases.吉非替尼长期治疗隐匿性肺癌伴多发脑转移
Lung Cancer. 2013 Apr;80(1):109-11. doi: 10.1016/j.lungcan.2012.12.009. Epub 2012 Dec 29.
5
Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.表皮生长因子受体（EGFR）基因拷贝数增加与非小细胞肺癌中的EGFR突变及腺癌密切相关：一项对182例患者的显色原位杂交研究。
Lung Cancer. 2008 Sep;61(3):328-39. doi: 10.1016/j.lungcan.2008.01.009. Epub 2008 Mar 4.
6
High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.台湾非小细胞肺癌中表皮生长因子受体突变频率高且模式复杂，与吉非替尼反应性相关
Clin Cancer Res. 2004 Dec 15;10(24):8195-203. doi: 10.1158/1078-0432.CCR-04-1245.
7
Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.晚期非小细胞肺癌中的表皮生长因子受体突变与酪氨酸激酶抑制剂治疗
Technol Eval Cent Assess Program Exec Summ. 2011 Mar;25(6):1-5.
8
Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.在日本非小细胞肺癌患者中，表皮生长因子受体突变与吉非替尼敏感性相关。
Lung Cancer. 2006 Jan;51(1):71-7. doi: 10.1016/j.lungcan.2005.08.006. Epub 2005 Sep 29.
9
Erlotinib in lung cancer - molecular and clinical predictors of outcome.厄洛替尼用于肺癌治疗——疗效的分子及临床预测指标
N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736.
10
EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer.在非小细胞肺癌中赋予对吉非替尼原发性耐药的表皮生长因子受体（EGFR）突变
N Engl J Med. 2005 Jul 14;353(2):207-8. doi: 10.1056/NEJM200507143530217.

引用本文的文献

1
The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.在多个原发性肺癌中鉴定出的致病变异体 ETV4 P433L 突变通过 Wnt/β-连环蛋白途径影响肿瘤干细胞样特性。
Cell Death Dis. 2024 Oct 10;15(10):738. doi: 10.1038/s41419-024-07129-z.
2
Identification of R776H germline mutations in a patient with multifocal lung adenocarcinoma: A case report and literature review.一名多灶性肺腺癌患者中R776H种系突变的鉴定：病例报告及文献综述
Respir Med Case Rep. 2024 May 27;50:102051. doi: 10.1016/j.rmcr.2024.102051. eCollection 2024.
3
Lung Cancer in Never Smokers: Delving into Epidemiology, Genomic and Immune Landscape, Prognosis, Treatment, and Screening.
非吸烟人群中的肺癌：深入探究流行病学、基因组和免疫景观、预后、治疗和筛查。
Lung. 2023 Dec;201(6):521-529. doi: 10.1007/s00408-023-00661-3. Epub 2023 Nov 16.
4
Germline Mutations and Familial Lung Cancer.胚系突变与家族性肺癌。
J Clin Oncol. 2023 Dec 1;41(34):5274-5284. doi: 10.1200/JCO.23.01372. Epub 2023 Oct 23.
5
Germline EGFR mutations in lung cancer (Review).肺癌中的种系表皮生长因子受体突变（综述）
Oncol Lett. 2023 May 16;26(1):282. doi: 10.3892/ol.2023.13868. eCollection 2023 Jul.
6
Two germline mutations can serve as genetic susceptibility screening makers for a lung adenocarcinoma family.两种种系突变可作为肺腺癌家族的遗传易感性筛查标志物。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6541-6548. doi: 10.1007/s00432-023-04616-2. Epub 2023 Feb 13.
7
A Primary Lung and Breast Cancer Patient with Germline R776H Mutation: A Case Report and Literature Review.一名携带胚系R776H突变的原发性肺癌和乳腺癌患者：病例报告及文献综述
Onco Targets Ther. 2023 Jan 18;16:17-22. doi: 10.2147/OTT.S391766. eCollection 2023.
8
Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules.病例报告：在一名多发性肺结节患者中鉴定出 EGFR R776H 和 FANCE R381H 种系突变。
J Cancer Res Clin Oncol. 2023 Feb;149(2):921-927. doi: 10.1007/s00432-022-04290-w. Epub 2022 Sep 26.
9
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.青少年和青年癌症易感基因：意大利 AYA 工作组的综述论文。
Curr Oncol Rep. 2022 Jul;24(7):843-860. doi: 10.1007/s11912-022-01213-3. Epub 2022 Mar 23.
10
Presentation of mutations in 162 family probands with multiple primary lung cancer.162例多原发性肺癌家族先证者的突变情况
Transl Lung Cancer Res. 2021 Apr;10(4):1734-1746. doi: 10.21037/tlcr-20-1001.